Review



fgfr detection  (Novus Biologicals)


Bioz Verified Symbol Novus Biologicals is a verified supplier
Bioz Manufacturer Symbol Novus Biologicals manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Novus Biologicals fgfr detection
    Kaplan-Meier curve showing OS probability among p40/TTF-1 double expressor NSCLC cases, comparing patients <t>with</t> <t>FGFR1</t> overexpression and/or amplification (FGFR1alt) to those without these alterations (FGFR1wt). The P value was calculated using the log-rank test. <t>FGFR,</t> fibroblast growth factor receptor; NSCLC, non-small cell lung cancer; OS, overall survival; wt, wild-type.
    Fgfr Detection, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 6 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fgfr+detection/FGFR1+Antibody+(Lilly+patent+anti-FGFR-1)/pmc12541837-72-4-9
    Average 93 stars, based on 6 article reviews
    fgfr detection - by Bioz Stars, 2026-11
    93/100 stars

    Images

    1) Product Images from "TTF-1 and p40 co-expression defines a distinct subtype of non-small cell lung cancer with frequent TP53 mutations and FGFR pathway dysregulation"

    Article Title: TTF-1 and p40 co-expression defines a distinct subtype of non-small cell lung cancer with frequent TP53 mutations and FGFR pathway dysregulation

    Journal: Translational Lung Cancer Research

    doi: 10.21037/tlcr-2025-690

    Kaplan-Meier curve showing OS probability among p40/TTF-1 double expressor NSCLC cases, comparing patients with FGFR1 overexpression and/or amplification (FGFR1alt) to those without these alterations (FGFR1wt). The P value was calculated using the log-rank test. FGFR, fibroblast growth factor receptor; NSCLC, non-small cell lung cancer; OS, overall survival; wt, wild-type.
    Figure Legend Snippet: Kaplan-Meier curve showing OS probability among p40/TTF-1 double expressor NSCLC cases, comparing patients with FGFR1 overexpression and/or amplification (FGFR1alt) to those without these alterations (FGFR1wt). The P value was calculated using the log-rank test. FGFR, fibroblast growth factor receptor; NSCLC, non-small cell lung cancer; OS, overall survival; wt, wild-type.

    Techniques Used: Over Expression, Amplification

    Related Articles

    Over Expression:

    Article Title: TTF-1 and p40 co-expression defines a distinct subtype of non-small cell lung cancer with frequent TP53 mutations and FGFR pathway dysregulation
    Article Snippet: Additional IHC staining was conducted for p53 (clone DO-7, Dako/Agilent), p63 (clone DAK-p63, Dako/Agilent), PD-L1 (clone 22C3, Dako/Agilent), and FGFR1–4 using 4 μm formalin-fixed, paraffin-embedded (FFPE) tumor sections following standardized protocols.Additional IHC staining was conducted for p53 (clone DO-7, Dako/Agilent), p63 (clone DAK-p63, Dako/Agilent), PD-L1 (clone 22C3, Dako/Agilent), and FGFR1–4 using 4 μm formalin-fixed, paraffin-embedded (FFPE) tumor sections following standardized protocols.. Primary antibodies used for FGFR detection were: FGFR1 (NB100-2080, Novus Biologicals, USA; pH 6.0, 1:100), FGFR2 (H00002263-M01, Abnova, Taiwan; pH 6.0, 1:600), FGFR3 (B-9: sc-13121, Santa Cruz Biotechnology; pH 6.0, 1:50), and FGFR4 (M00769-2, Boster Bio, USA; pH 6.0, 1:500).. Gastric and lobular breast ADCs were used as positive controls, while lymph node tissue served as the negative control.Gastric and lobular breast ADCs were used as positive controls, while lymph node tissue served as the negative control.

    Amplification:

    Article Title: TTF-1 and p40 co-expression defines a distinct subtype of non-small cell lung cancer with frequent TP53 mutations and FGFR pathway dysregulation
    Article Snippet: Additional IHC staining was conducted for p53 (clone DO-7, Dako/Agilent), p63 (clone DAK-p63, Dako/Agilent), PD-L1 (clone 22C3, Dako/Agilent), and FGFR1–4 using 4 μm formalin-fixed, paraffin-embedded (FFPE) tumor sections following standardized protocols.Additional IHC staining was conducted for p53 (clone DO-7, Dako/Agilent), p63 (clone DAK-p63, Dako/Agilent), PD-L1 (clone 22C3, Dako/Agilent), and FGFR1–4 using 4 μm formalin-fixed, paraffin-embedded (FFPE) tumor sections following standardized protocols.. Primary antibodies used for FGFR detection were: FGFR1 (NB100-2080, Novus Biologicals, USA; pH 6.0, 1:100), FGFR2 (H00002263-M01, Abnova, Taiwan; pH 6.0, 1:600), FGFR3 (B-9: sc-13121, Santa Cruz Biotechnology; pH 6.0, 1:50), and FGFR4 (M00769-2, Boster Bio, USA; pH 6.0, 1:500).. Gastric and lobular breast ADCs were used as positive controls, while lymph node tissue served as the negative control.Gastric and lobular breast ADCs were used as positive controls, while lymph node tissue served as the negative control.



    Similar Products

    93
    Novus Biologicals fgfr detection
    Kaplan-Meier curve showing OS probability among p40/TTF-1 double expressor NSCLC cases, comparing patients <t>with</t> <t>FGFR1</t> overexpression and/or amplification (FGFR1alt) to those without these alterations (FGFR1wt). The P value was calculated using the log-rank test. <t>FGFR,</t> fibroblast growth factor receptor; NSCLC, non-small cell lung cancer; OS, overall survival; wt, wild-type.
    Fgfr Detection, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fgfr+detection/FGFR1+Antibody+(Lilly+patent+anti-FGFR-1)/pmc12541837-72-4-9
    Average 93 stars, based on 1 article reviews
    fgfr detection - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    90
    Empire Genomics detection of fgfr gene translocations
    Kaplan-Meier curve showing OS probability among p40/TTF-1 double expressor NSCLC cases, comparing patients <t>with</t> <t>FGFR1</t> overexpression and/or amplification (FGFR1alt) to those without these alterations (FGFR1wt). The P value was calculated using the log-rank test. <t>FGFR,</t> fibroblast growth factor receptor; NSCLC, non-small cell lung cancer; OS, overall survival; wt, wild-type.
    Detection Of Fgfr Gene Translocations, supplied by Empire Genomics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fgfr+detection/detection+of+fgfr+gene+translocations/us10208024-636-24-40
    Average 90 stars, based on 1 article reviews
    detection of fgfr gene translocations - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    Image Search Results


    Kaplan-Meier curve showing OS probability among p40/TTF-1 double expressor NSCLC cases, comparing patients with FGFR1 overexpression and/or amplification (FGFR1alt) to those without these alterations (FGFR1wt). The P value was calculated using the log-rank test. FGFR, fibroblast growth factor receptor; NSCLC, non-small cell lung cancer; OS, overall survival; wt, wild-type.

    Journal: Translational Lung Cancer Research

    Article Title: TTF-1 and p40 co-expression defines a distinct subtype of non-small cell lung cancer with frequent TP53 mutations and FGFR pathway dysregulation

    doi: 10.21037/tlcr-2025-690

    Figure Lengend Snippet: Kaplan-Meier curve showing OS probability among p40/TTF-1 double expressor NSCLC cases, comparing patients with FGFR1 overexpression and/or amplification (FGFR1alt) to those without these alterations (FGFR1wt). The P value was calculated using the log-rank test. FGFR, fibroblast growth factor receptor; NSCLC, non-small cell lung cancer; OS, overall survival; wt, wild-type.

    Article Snippet: Primary antibodies used for FGFR detection were: FGFR1 (NB100-2080, Novus Biologicals, USA; pH 6.0, 1:100), FGFR2 (H00002263-M01, Abnova, Taiwan; pH 6.0, 1:600), FGFR3 (B-9: sc-13121, Santa Cruz Biotechnology; pH 6.0, 1:50), and FGFR4 (M00769-2, Boster Bio, USA; pH 6.0, 1:500).

    Techniques: Over Expression, Amplification